Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Both sides next revision
sars-cov-2:origins:venom_poisoning_hypothesis [2022/08/06 18:42]
liam [Additional Interviews]
sars-cov-2:origins:venom_poisoning_hypothesis [2022/08/06 18:42] (current)
liam [Snake Venom in Biotechnology]
Line 20: Line 20:
  
 === Nanofibrous Snake Venom Hemostat === === Nanofibrous Snake Venom Hemostat ===
-A "self-assembling nanofibrous peptide hydrogel (termed SLac) that on its own can act as a physical barrier to blood loss," has been described in a 2015 paper.((October 20, 2022 | Vivek Kumar et al | ACS Biomater Sci Eng. (journal) | Nanofibrous Snake Venom Hemostat | [[https://pubmed.ncbi.nlm.nih.gov/26753175/|doi: 10.1021/acsbiomaterials.5b00356]]))+ 
 +A "self-assembling nanofibrous peptide [[:hydrogel]] (termed SLac) that on its own can act as a physical barrier to blood loss," has been described in a 2015 paper.((October 20, 2022 | Vivek Kumar et al | ACS Biomater Sci Eng. (journal) | Nanofibrous Snake Venom Hemostat | [[https://pubmed.ncbi.nlm.nih.gov/26753175/|doi: 10.1021/acsbiomaterials.5b00356]]))
  
 === Monoclonal and Polyclonal Antibodies === === Monoclonal and Polyclonal Antibodies ===
Print/export